Novartis AG (NVSEF)
96.00
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Novartis 1 Year Total Returns (Daily): 14.39% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 25, 2024 | 14.39% |
| April 24, 2024 | 19.42% |
| April 23, 2024 | 19.42% |
| April 22, 2024 | 18.32% |
| April 19, 2024 | 14.55% |
| April 18, 2024 | 14.55% |
| April 17, 2024 | 18.86% |
| April 16, 2024 | 18.86% |
| April 15, 2024 | 18.86% |
| April 12, 2024 | 20.96% |
| April 11, 2024 | 22.30% |
| April 10, 2024 | 22.90% |
| April 09, 2024 | 23.75% |
| April 08, 2024 | 22.73% |
| April 05, 2024 | 24.22% |
| April 04, 2024 | 27.37% |
| April 03, 2024 | 24.92% |
| April 02, 2024 | 29.58% |
| April 01, 2024 | 31.64% |
| March 28, 2024 | 35.66% |
| March 27, 2024 | 43.86% |
| March 26, 2024 | 43.86% |
| March 25, 2024 | 43.86% |
| March 22, 2024 | 44.92% |
| March 21, 2024 | 44.92% |
| Date | Value |
|---|---|
| March 20, 2024 | 42.44% |
| March 19, 2024 | 46.74% |
| March 18, 2024 | 51.43% |
| March 15, 2024 | 54.06% |
| March 14, 2024 | 52.45% |
| March 13, 2024 | 49.28% |
| March 12, 2024 | 52.14% |
| March 11, 2024 | 52.79% |
| March 08, 2024 | 58.42% |
| March 07, 2024 | 62.29% |
| March 06, 2024 | 51.30% |
| March 05, 2024 | 54.39% |
| March 04, 2024 | 54.39% |
| March 01, 2024 | 55.77% |
| February 29, 2024 | 52.39% |
| February 28, 2024 | 58.27% |
| February 27, 2024 | 53.95% |
| February 26, 2024 | 50.79% |
| February 23, 2024 | 49.14% |
| February 22, 2024 | 47.73% |
| February 21, 2024 | 46.38% |
| February 20, 2024 | 46.38% |
| February 16, 2024 | 43.76% |
| February 15, 2024 | 42.89% |
| February 14, 2024 | 40.61% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-12.72%
Minimum
Mar 18 2020
68.69%
Maximum
Oct 13 2023
13.44%
Average
9.26%
Median
Apr 07 2022
1 Year Total Returns (Daily) Benchmarks
| Sandoz Group AG | -- |
| Roche Holding AG | -21.48% |
| Bristol-Myers Squibb Co | -33.63% |
| Eli Lilly and Co | 89.92% |